| 产品名称： | Glarea lozoyensis Bills et Pelaez |
|---|---|
| 商品货号： | TS158202 |
| Deposited As： | Zalerion arboricola Buczacki |
| Strain Designations： | MF5416 Z13-62 |
| Application： | produces echinocandin B deriviatives produces pneumocandin A4 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 24°C |
| Sequenced Data： | No DNA sequencing was performed in house on this product.
|
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | mutant derived from ATCC 20958 |
| References： | Fountoulakis JM, Masurekar PS. Process for production of an antibiotic compound using Zalerion arboricola. US Patent 5,137,813 dated Aug 11 1992 Masurekar PS, et al. Pneumocandins from Zalerion arboricola. II. Modification of productspectrum by mutation and medium manipulation. J. Antibiot. 45: 1867-1874, 1992. PubMed: 1490877 Bills GF, et al. Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis gen. et sp. nov., previously identified as Zalerion arboricola. Mycol. Res. 103: 179-192, 1999. |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Glarea lozoyensis Bills et Pelaez |
|---|---|
| 商品货号： | TS158202 |
| Deposited As： | Zalerion arboricola Buczacki |
| Strain Designations： | MF5416 Z13-62 |
| Application： | produces echinocandin B deriviatives produces pneumocandin A4 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Type Strain： | no |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions： | Temperature: 24°C |
| Sequenced Data： | No DNA sequencing was performed in house on this product.
|
| Name of Depositor： | Merck & Co., Inc. |
| U.S. Patent Number： | |
| Isolation： | mutant derived from ATCC 20958 |
| References： | Fountoulakis JM, Masurekar PS. Process for production of an antibiotic compound using Zalerion arboricola. US Patent 5,137,813 dated Aug 11 1992 Masurekar PS, et al. Pneumocandins from Zalerion arboricola. II. Modification of productspectrum by mutation and medium manipulation. J. Antibiot. 45: 1867-1874, 1992. PubMed: 1490877 Bills GF, et al. Reclassification of a pneumocandin-producing anamorph, Glarea lozoyensis gen. et sp. nov., previously identified as Zalerion arboricola. Mycol. Res. 103: 179-192, 1999. |
